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        Asthma is a chronic disease characterized by in-
creased airway infl  ammation, enhanced mucus 
production, and constriction of the airways (  1  ). 
The adaptive immune response, in particular 
Th2 cells, plays a major role in the pathogenesis 
of airway infl  ammation. Th2 cytokines such as 
IL-4, IL-5, and IL-13 produced by activated 
CD4      T cells exacerbate the severity of the 
disease (  2  ). Additionally, an important contri-
bution of B cells in the pathogenesis of asthma 
is underlined by the central role for IgE in the 
activation and degranulation of mast cells (  3  ). 
  Allergen-specifi  c IgG is also present in the 
serum of allergic individuals; however, its exact 
role in asthma and allergy remains controversial 
(  4  –  8  ). Allergen hyposensitization therapy in-
volves   “  tolerizing  ”   atopic individuals by long-
term exposure to allergen. The success of this 
therapy has been correlated to increased serum 
IgG  4   levels (  9  ). Antigen-specifi  c IgG has been 
thought to exert its suppressive eff  ects through 
diff  erent pathways that include competing with 
IgE for allergen epitopes and activation of in-
hibitory Fc      receptors (  10  ). In sharp contrast, 
a recent study by the Multicentre Allergy Study 
Group has demonstrated that the presence of 
antigen-specifi  c IgG, in addition to antigen-
specifi  c IgE, increased the incidence of asthma 
symptoms in children (  11  ). One possible expla-
nation for these contradictory results may be the 
nature of the IgG isotype produced in each in-
dividual, as well as the preferential ligation of 
certain IgG isotypes to activating versus inhibi-
tory Fc      receptors. 
  Activating Fc      receptors possess immuno-
receptor tyrosine-based activation motifs, whereas 
inhibitory Fc      receptors possess immunoreceptor 
tyrosine-based inhibition motifs in their intra-
cellular domain. The activating receptors Fc     RI 
(CD64) and Fc     RIII (CD16) signal through a 
common signaling partner FcR     (Fc    RI     ), which 
contains an immunoreceptor tyrosine-based 
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  Although inhibitory Fc     receptors have been demonstrated to promote mucosal tolerance, 
the role of activating Fc     receptors in modulating T helper type (Th)2-dependent infl  am-
matory responses characteristic of asthma and allergies remains unclear. Here, we demon-
strate that signaling via activating Fc     receptors in conjunction with Toll-like receptor 4 
stimulation modulated cytokine production from bone marrow  –  derived dendritic cells (DCs) 
and augmented their ability to promote Th2 responses. Ligation of the low affi  nity receptor 
Fc    RIII was specifi  cally required for the enhanced Th2 responses, as Fc    RIII      /      DCs failed to 
augment Th2-mediated airway infl  ammation in vivo or induce Th2 differentiation in vitro. 
Further, Fc    RIII      /      mice had impaired Th2 cytokine production and exhibited reduced 
airway infl  ammation, whereas no defect was found in Fc    RI      /      mice. The augmentation 
of Th2 immunity was regulated by interleukin 10 production from the DCs but was distinct 
and independent of the well-established role of Fc    RIII in augmenting antigen presentation. 
Thus, our studies reveal a novel and specifi  c role for Fc    RIII signaling in the regulation of 
Th cell responses and suggest that in addition to immunoglobulin (Ig)E, antigen-specifi  c IgG 
also contributes to the pathogenesis of Th2-mediated diseases such as asthma and allergies. 1876 FC RIII REGULATES TH2 RESPONSES | Bandukwala et al.
served as the TLR-4 stimulus. Upon Fc receptor ligation, 
TLR-4  –  induced IL-10 production by the bone marrow  – 
derived DCs (BMDCs) was signifi  cantly up-regulated, whereas 
IL-12 production was suppressed (  Fig. 1 A  ).   The ability of 
Fc      receptors to modulate BMDC cytokine production was 
TLR-4 dependent, as OVA-ICs failed to modulate cytokine 
production from TLR-4       /       DCs. Polymixin B  –  mediated 
depletion of LPS from the OVA also abolished the ability of 
OVA-ICs to infl  uence DC cytokine production (unpub-
lished data). Further, Fc      receptor ligation also augmented 
production of the chemokine monocyte chemoattractant 
protein (MCP)-1, which has been shown to promote Th2 
diff  erentiation (  29  ). 
  To physically dissociate the TLR-4 stimulus from Fc      
receptor ligation, we sought to cross-link Fc      receptors with 
an immobilized antibody specifi  c for Fc     RIIb/RIII (2.4G2) 
(  30, 31  ). BMDCs were stimulated with 10 ng/ml LPS with 
varying concentrations of 2.4G2. As found with OVA-IC 
stimulation, ligation of Fc      receptors on BMDCs with 2.4G2 
resulted in a dose-dependent increase in IL-10 and MCP-1 
production, and a decrease in IL-12 production (  Fig. 1 B  ). 
Collectively, these data suggest that Fc      receptor ligation 
modulates TLR-induced DC functions and augments cyto-
kines known to promote a pro-Th2 milieu. 
activation motif and is also associated with the high affi   nity re-
ceptor for IgE. A novel member of the Fc      receptor family, 
Fc     RIV, has been recently described (12). Fc     RIV also asso-
ciates with the FcR      signaling chain, suggesting its role as an 
activating Fc      receptor (  12  ). Fc     RIIb (CD32b) is the sole 
member of the inhibitory Fc      receptor family in mice and 
does not associate with FcR     . It has been demonstrated that 
ligation of the inhibitory Fc     RIIb can suppress Fc      receptor 
signaling and ameliorate airway disease (  13  ). Fc     RIIb has also 
been shown to promote tolerance to inhaled antigens (  14  ). 
Thus, the role of inhibitory Fc      receptors in suppressing Th2-
mediated infl  ammatory responses is well documented; how-
ever, the role of activating Fc      receptors remains unclear. 
  Activating Fc      receptors have both overlapping and non-
redundant roles. Signaling via both Fc     RI and Fc     RIII on 
macrophages has been demonstrated to enhance phagocyto-
sis of opsonized RBCs and antigen presentation to T cells 
(  15, 16  ). However, evidence of nonredundant roles is pro-
vided by studies that demonstrate that both Fc     RI       /       and 
Fc     RIII       /       mice exhibit marked defects in their ability to 
mount Arthus reactions and have reduced susceptibility to 
passive anaphylaxis (  16  –  18  ). In addition, the development of 
proteoglycan-induced arthritis was found to require Fc     RIII 
but not Fc     RI expression (  19  ). The inability of the individ-
ual Fc      receptors to compensate for each other may be ex-
plained by selective affi   nity of each receptor for a subtype of 
IgG antibodies. Fc     RI binds IgG  2a   antibodies with     100-
fold higher affi   nity than Fc     RIII (  12, 20, 21  ), and Fc     RI is a 
high affi   nity receptor for monomeric IgG antibodies, whereas 
Fc     RIII is thought to be a low affi   nity receptor that is en-
gaged effi   ciently by IgG  1    –  immune complexes (  15, 18  ). 
  In this study, we investigated whether activating Fc      re-
ceptors regulate Th2-dependent infl  ammatory responses. We 
demonstrate that signaling via Fc     RIII on DCs plays a key 
role in the development of optimal Th2-dependent airway 
infl  ammation. This augmentation of Th2 immunity by Fc     RIII 
ligation is distinct from its role in antigen presentation and 
mediated by IL-10 production by the priming DCs. Our 
data suggest a novel role for Fc     RIII on DCs in augment-
ing in vivo Th2 responses and the exacerbation of airway 
infl  ammation. 
    RESULTS   
  Ligation of Fc     receptors modulates Toll-like receptor 
(TLR)-4  –  mediated cytokine production from DCs 
  DCs are thought to play a critical role in the regulation of Th 
cell diff  erentiation (  22  ) and for the development of airway 
infl  ammation (  23  –  25  ). As DCs have been shown to express 
all Fc      receptors (  12, 26  –  28  ), we investigated the contribu-
tion of Fc      receptor ligation in TLR-4  –  induced stimulation 
of DCs. Immune complexes were produced by incubation of 
OVA with anti-OVA sera (OVA immune complexes [OVA-
ICs]) and used to ligate Fc      receptors. To control for poten-
tial nonspecifi  c eff  ects from the antisera, an aliquot of antisera 
in which IgG had been depleted was incubated with OVA 
(OVA-IgG  depl  ). 22.1 EU/mg endotoxin present in the OVA 
  Figure 1.     Ligation of Fc      receptors modulates TLR-4  –  mediated 
cytokine production from DCs. (A) BMDCs generated from BALB/c 
(fi  lled bars) or C.C3-Tlr4    Lps-d    (TLR-4     /     ) (open bars) mice were loaded with 
immune complexes produced by incubation of OVA with anti-OVA sera 
(OVA-IC) or OVA mixed with an aliquot of antisera in which IgG had been 
depleted (OVA-IgG  depl  ) to account for potential nonspecifi  c effects from 
the antisera (***, P   0.001; n.d., not detected). (B) BALB/c (fi  lled bars) or 
TLR-4      /      (open bars) BMDCs were cultured on plates coated with the 
indicated concentration of anti-Fc     RIIb/RIII (2.4G2) in the presence of 
10 ng/ml LPS. After 24 h of culture, cytokine production from the BMDCs 
was estimated. Fc      receptor – mediated  modulation  of  cytokine  production 
was signifi  cantly reduced in the TLR-4      /      BMDCs as compared with BALB/c 
BMDCs (P   0.005 by two-way ANOVA analysis). The data shown in A 
are representative of three independent experiments, and those presented 
in B are representative of two independent experiments.     JEM VOL. 204, August 6, 2007 
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Fc     RIII as well as the inhibitory receptor Fc     RIIb (  27  ). To dis-
sect whether the modulation of DC function was due to acti-
vating or inhibitory Fc      receptors, we generated BMDCs from 
Fc     RIIb    −  /  −    and Fc     RIII    −  /  −    mice as well as from FcR         −  /  −   mice 
that lack all activating Fc receptors. Interestingly, modula-
tion of IL-10 and IL-12 production upon 2.4G2 stimulation 
was dependent on expression of FcR      chain and Fc     RIII, 
but deletion of Fc     RIIb actually enhanced the changes 
induced by the activating Fc      receptors (  Fig. 3 A  ).   These 
data suggest that the modulation of cytokine production 
is dependent on signaling through the activating Fc      recep-
tors and that this signaling can be counteracted by the inhibi-
tory Fc     RIIb. 
  Ligation of activating Fc      receptors has been shown to 
activate various signaling pathways including ERK, p38, and 
phosphatitylinositol-3 kinase (PI3K) (  33  ). To ascertain the 
contribution of these signaling pathways in augmenting IL-10 
production from the DCs, we stimulated BMDCs with LPS 
and 2.4G2 in the presence of selective inhibitors of p38 
(SB202190), ERK (U0126), and PI3K (Ly294002) (  Fig. 3 B  ). 
The PI3K inhibitor blocked 2.4G2-induced IL-10 produc-
tion in a dose-dependent manner. In contrast, inhibition of 
ERK and p38 did not result in a signifi  cant reduction of 
IL-10 production. Collectively, these data suggest that signal-
ing via activating Fc      receptors leads to a PI3K-dependent 
modulation of DC cytokine production. 
  Ligation of Fc     receptors on the priming DC augments 
airway infl  ammation 
  To determine if modulation of DC function upon Fc      receptor 
ligation augments the ability of the DCs to induce Th2-mediated 
airway infl  ammation, we used DCs stimulated with a control rat 
IgG or 2.4G2 to sensitize naive mice. BMDCs were treated with 
2.4G2 or a control antibody in the presence of OVA. After 24 h, 
the BMDCs were harvested and instilled intratracheally (i.t.) 
into naive recipients that were subsequently challenged with 
OVA on days 7, 8, and 9 (  32  ). The mice were killed 24 h after 
the last challenge, and the extent of airway infl  ammation was 
assessed by determining the cellular composition in the bron-
choalveolar lavage (BAL) fl  uid. Mice sensitized with 2.4G2-
treated DCs exhibited increased numbers of eosinophils as well 
as CD4      T cells compared with mice sensitized with control 
DCs (  Fig. 2 A  ).   Analysis of cytokine production from the CD4      
T cells in the BAL (  Fig. 2 B  ) and the lungs (  Fig. 2 C  ) revealed 
an increase in the percentage of IL-4      and IL-5      cells, indicat-
ing an increase in Th2 eff  ector responses. These data demon-
strate that signaling via Fc      receptors on the priming DCs is 
suffi   cient to augment in vivo Th2 responses. 
  Modulation of cytokine production by 2.4G2 requires 
expression of activating Fc     receptors on the DCs 
  The monoclonal antibody 2.4G2 that we used in the previ-
ous experiments can ligate both the activating Fc      receptor 
  Figure 2.     Ligation of Fc      receptors on the priming DCs augments Th2-mediated airway infl  ammation and cytokine production in vivo. 
BMDCs generated from B6 mice were cultured on a nonspecifi  c control rat IgG (open bars) or anti-Fc     RIIb/RIII (2.4G2) (fi  lled bars)   –  coated plates along 
with OVA. After 24 h, these DCs were harvested and instilled i.t. into naive B6 recipient mice. After sensitization, the recipient mice were challenged with 
soluble OVA i.t. daily for 3 d starting on day 7, and BAL was performed 24 h after last challenge. (A) Airway infl  ammation was assessed by determining 
the cellular composition of the BAL fl  uid (*, P   0.05; **, P   0.01; ***, P   0.001). The error bars indicate variation between individual mice. (B) For each group, 
the BAL cells were pooled and cytokine production of the CD4      T cells was determined by intracellular staining. (C) Pooled lung cells were restimulated in 
vitro with OVA for 48 h, and cytokine production was assessed by ELISPOT analysis (**, P   0.01; ***, P   0.001). The error bars indicate the SEM between 
replicate stimulations in different wells. The data represented in this fi  gure were obtained from three independent experiments, and 9  –  10 mice per group 
were  analyzed.   1878 FC RIII REGULATES TH2 RESPONSES | Bandukwala et al.
IL-5, and IL-13, as well as IL-10 (  Fig. 4 B  ). The amount of 
IFN-      produced by the T cells was relatively low, and no 
signifi  cant changes were observed in IFN-      production in 
any of the experimental groups. 
  In this experimental system, only the priming DCs had a 
defect in Fc     RIII expression, whereas the expression of Fc     RIII 
on all other cells was unaltered. Thus, these data suggest an im-
portant role for Fc     RIII signaling on the priming DCs for the 
stimulatory eff  ects of OVA-IC treatment on Th2 responses in 
vivo. Furthermore, these data suggest a specifi  c requirement 
of Fc     RIII expression on DCs for the augmentation of Th2-
mediated airway infl  ammation, as other Fc      receptors could 
not compensate for the defi  ciency of Fc     RIII. 
  Deletion of Fc    RIII on DCs does not diminish their ability 
to process or present antigens to CD4     T cells 
  One possible mechanism by which Fc     RIII defi  ciency on 
BMDCs leads to the reduction of Th2 responses could be de-
creased uptake and processing of immune complexes and di-
minished antigen presentation to CD4      T cells. To investigate 
this possibility, we fi   rst analyzed the ability of B6 and 
Fc     RIII       /       BMDCs to internalize and process immune-
complexed antigens. To quantitate the ability of Fc      receptors 
to enhance uptake and processing of internalized antigens, we 
used DQ-OVA, a self-quenching conjugate that fl  uoresces 
only upon proteolysis (  34  ). Increased fl  uorescence in this case 
would be representative of internalization and processing of 
antigens, and not just due to increased surface binding of 
  immune-complexed antigens. B6 and Fc     RIII       /       DCs were 
  Signaling via Fc    RIII on the priming DCs is required 
for immune complex  –  mediated up-regulation 
of airway infl  ammation 
  As Fc     RIII is the sole activating Fc      receptor engaged by 
2.4G2, the data from the previous experiments suggested that 
Fc     RIII signaling could play an important role in the augmen-
tation of Th2-mediated airway infl  ammation. To investigate 
whether Fc     RIII is required for Fc      receptor  –  mediated aug-
mentation of Th2-dependent airway infl  ammation or can be 
compensated for by other activating Fc      receptors, OVA-ICs 
were used to ligate Fc      receptors on Fc     RIII       /       BMDCs. 
  BMDCs generated from C57BL/6 (B6) and Fc     RIII       /       
were cultured with either OVA-IC or control OVA-IgG  depl   
and instilled i.t. to sensitize naive B6 recipients. The recipi-
ents were challenged as in   Fig. 2,   and the severity of airway 
infl  ammation was determined on day 10. BAL eosinophilia 
was signifi  cantly increased in mice that were sensitized with 
B6 DCs loaded with OVA-IC as compared with mice sensi-
tized with B6 DCs loaded with OVA-IgG  Depl   (  Fig. 4 A  ).   
However, Fc     RIII       /       DCs loaded with OVA-IC failed to 
augment eosinophilia in recipient mice. Similarly, further 
evaluation of Th2 responses in the LNs revealed an augmen-
tation of IL-4, IL-5, and IL-13 production by T cells from 
recipients that were sensitized with OVA-IC  –  loaded B6 
DCs. The production of the pleiotropic cytokine IL-10 was 
also coordinately up-regulated along with the classical Th2 
cytokines from T cells stimulated with OVA-IC  –  loaded 
B6 DCs. However, OVA-IC  –  loaded Fc     RIII       /       DCs failed 
to augment production of all bonafi  de Th2 cytokines: IL-4, 
  Figure 3.     Modulation of cytokine production by 2.4G2 requires expression of activating Fc      receptors on the DCs. (A) BMDCs generated from 
B6 or Fc      receptor – defi  cient mice were stimulated with 10 ng/ml LPS along with a control IgG or anti-Fc     RIIb/RIII (2.4G2). The amount of cytokines pres-
ent in culture supernatants was determined by ELISA. The amount of cytokine produced upon 2.4G2 treatment was normalized to the amount produced 
upon treatment with control IgG (**, P   0.01; ***, P   0.001). (B) The fold increase in IL-10 production from DCs stimulated with 2.4G2 in the presence of 
the indicated concentrations of ERK inhibitor (U0126), p38 inhibitor (SB202190), and PI3K inhibitor (Ly294002) was determined. The data shown in this 
fi  gure are representative of two independent experiments. The error bars indicate variation between replicate stimulations in different wells (P   0.0001 
by one-way ANOVA analysis).     JEM VOL. 204, August 6, 2007 
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whether Fc     RIII       /       DCs had any defect in their ability to 
prime Th2 diff  erentiation. OTII T cells stimulated with B6 
DCs loaded with OVA-IC produced augmented levels of 
Th2 cytokines IL-4, IL-10, and IL-13 as compared with DCs 
loaded with OVA alone (  Fig. 6 A  ).   However, Fc     RIII       /       
DCs loaded with OVA-IC failed to augment Th2 cytokine 
production but were able to up-regulate IFN-      production 
from the T cells similar to that induced by B6 DCs loaded 
with OVA-IC. These data argue that Fc     RIII       /       DCs do not 
have a global impairment in responding to immune complexes 
but nevertheless fail to augment Th2 cytokine production in 
these cultures. 
  Finally, to investigate if the increase in antigen processing 
was required for augmented Th2 diff  erentiation by DCs upon 
Fc      receptor signaling, we eliminated the need for antigen 
uptake and processing. Control- or 2.4G2-treated DCs were 
loaded with the agonist OVA  323  –  339   peptide that can directly 
bind to MHC class II molecules present on the cell surface 
and hence does not require antigen processing. These DCs 
were used to stimulate TCR transgenic T cells, and cytokine 
production from the T cells was assessed. 2.4G2-treated DCs 
augmented Th2 cytokine production from the T cells as com-
pared with control-treated DCs, even when T cell prolifera-
tion induced by these DCs was made independent of antigen 
uptake and processing (  Fig. 6 B  ). Again, this eff  ect was de-
pendent on activating Fc      receptors because 2.4G2 treatment 
failed to augment the ability of Fc     RIII       /       DCs to induce 
Th2 diff  erentiation (  Fig. 6 C  ). Collectively, these data demon-
strate that increased antigen presentation by the DCs upon Fc      
receptor ligation is not required for the increase in Th2 dif-
ferentiation and argue for a distinct role for Fc     RIII signaling 
in regulating DC-directed Th diff  erentiation. 
incubated with DQ-OVA or DQ-OVA-IC for 15 min at 
37  °  C to allow for uptake. After extensive washing to remove 
any un-internalized OVA, the cells were incubated for the in-
dicated times at 37  °  C and amount of processing was quanti-
tated as an increase in FITC fl  uorescence. As early as 5 min, 
both B6 and Fc     RIII       /       BMDCs exhibited an enhanced 
ability to internalize and process DQ-OVA-IC as compared 
with uncomplexed DQ-OVA (  Fig. 5 A  ).   At later time points, 
similar to B6 DCs, Fc     RIII       /       DCs loaded with DQ-OVA-
IC exhibited an accelerated rate of processing compared with 
Fc     RIII       /       DCs loaded with uncomplexed DQ-OVA. 
Thus, neither the ability of the DCs to take up antigen nor the 
ability of the DCs to augment processing of immune com-
plexes was diminished in the absence of Fc     RIII expression. 
  To determine whether Fc     RIII       /       DCs had an impair-
ment in stimulating T cell proliferation that was distinct from 
their ability to internalize and process antigens, OVA-pulsed B6 
and Fc     RIII       /       DCs were used to stimulate proliferation of 
TCR transgenic T cells from the OVA-specifi  c OTII mice. 
Pulsing DCs with immune complexes dramatically increased 
proliferation of the responding T cells (  Fig. 5 B  ). However, 
Fc     RIII       /       and B6 DCs were equally effi   cient at augmenting 
T cell proliferation when loaded with OVA-IC. These data 
demonstrate that Fc     RIII       /       DCs exhibit no defect in the abil-
ity to internalize, process, or present antigens and can induce 
expansion of T cells equivalent to that induced by B6 DCs. 
  Augmentation of Th2 differentiation requires Fc    RIII 
expression but is independent of increased antigen 
presentation by the DCs 
  As no appreciable defect was found in the ability of Fc    RIII       /       
DCs to drive T cell expansion in vitro, we investigated 
  Figure 4.     Immune complexes up-regulate Th2 responses by cross-linking Fc     RIII on DCs. BMDCs generated from B6 or Fc    RIII      /       mice  were 
loaded with immune complexes produced by incubation of OVA with anti-OVA sera (OVA-IC; fi  lled bars) or OVA mixed with an aliquot of antisera in which 
IgG had been depleted (OVA-IgG  depl  ; open bars). These DCs were instilled i.t. into naive B6 recipient mice challenged and analyzed as in Fig. 2. (A) Airway 
infl  ammation was assessed by determining the cellular composition of the BAL fl  uid (**, P   0.01; ***, P   0.001). (B) LN cells were restimulated in vitro 
with OVA for 48 h, and the amount of cytokines in culture supernatants was determined by ELISA (*, P   0.05; **, P   0.01; ***, P   0.001). The data 
represented in this fi  gure were obtained from two independent experiments. At least seven mice per group were analyzed.     1880 FC RIII REGULATES TH2 RESPONSES | Bandukwala et al.
reduced the amount of IL-12 production from IL-10       /       DCs. 
These data suggest that in addition to the autocrine suppression 
of IL-12 production induced by IL-10, Fc      receptor ligation 
leads to distinct signaling events that can suppress IL-12 pro-
duction in an IL-10  –  independent manner. Upon stimulation 
with OVA-ICs, MCP-1       /       DCs showed augmentation of 
IL-10 production and a suppression of IL-12 production similar 
to that induced by OVA-IC  –  treated B6 DCs (unpublished data). 
  To determine if production of these cytokines by DCs 
directly infl  uenced Fc      receptor  –  mediated augmentation of 
Th2 diff   erentiation, we assessed the ability of OVA-IC  –
  loaded IL-10       /       or MCP-1       /       DCs to induce Th2 diff  eren-
tiation of OTII T cells. Diff  erentiation of OTII T cells with 
IL-10       /       DCs loaded with OVA-IC failed to induce aug-
mented T cell production of IL-4, yet induced increased levels 
of IFN-      (  Fig. 7 B  ). Unexpectedly, OTII T cells stimulated 
with OVA-IC  –  loaded MCP-1       /       DCs exhibited no defects 
in their ability to enhance Th2 diff  erentiation (  Fig. 7 C  ). 
Collectively, our data suggest a central role for IL-10 in aug-
menting the ability of DCs to direct Th2 diff  erentiation upon 
Fc      receptor ligation, whereas MCP-1 production from the 
DCs was found to be dispensable. 
  IL-10 production from the DCs plays a key role in Fc     
receptor  –  mediated augmentation of Th2 differentiation 
  Although the mechanism by which DCs augment Th2 re-
sponses remains controversial, it has been suggested that 
modulation of DC cytokine production infl  uences the diff  er-
entiation status of responding T cells (  35, 36  ). Several studies 
have demonstrated an important role of DC cytokines IL-10 
and MCP-1 in the augmentation of Th2 responses (  29, 37  –  39  ). 
We demonstrated in   Figs. 1 and 3   that ligation of activating 
Fc      receptors on DCs led to the potent up-regulation of 
IL-10 and MCP-1. To elucidate the contribution of these cy-
tokines in the modulation of DC function upon Fc      receptor 
engagement, we stimulated B6, IL-10       /      , and MCP-1       /       
BMDCs with control OVA or OVA-IC and analyzed cyto-
kine production from the DCs after 24 h of stimulation. 
  In agreement with previous reports (  37, 40  ), IL-10       /       DCs 
exhibited increased levels of IL-12 production as compared 
with B6 DCs when stimulated with OVA (  Fig. 7 A  ).   How-
ever, ligation of Fc      receptors with OVA-IC signifi  cantly 
  Figure 5.     BMDCs from Fc     RIII       /      mice do not have a defect in 
antigen uptake, processing, or presentation. (A) To measure antigen 
uptake and processing, DQ-OVA (    ) or DQ OVA-ICs (    ) were loaded onto 
BMDCs generated from B6 (solid lines) or Fc    RIII      /       (dashed lines) mice. 
The cells were incubated at 37  °  C, and the amount of OVA processed into 
peptides was measured at the indicated time points as an increase in FITC 
fl  uorescence. Error bars represent variation observed between indepen-
dent experiments. Statistical data presented were obtained using a two-
way ANOVA analysis. The bottom panel depicts a representative histogram 
of the data obtained at 60 min. The shaded histograms represent baseline 
60 min. (B) CFSE-dyed OTII TCR transgenic T cells were cultured for 96 h 
with B6 or Fc    RIII     /      DCs loaded with OVA (open bars) or OVA-IC (fi  lled 
bars). The extent of proliferation was assessed as a dilution of the CFSE 
dye (P   0.0001 by two-way ANOVA analysis).     
  Figure 6.     T cells exhibit reduced Th2 differentiation upon stimula-
tion with Fc     RIII      /      BMDCs. (A) OTII T cells were cultured with OVA-
IgG  Depl   (open bars) or OVA-IC (fi  lled bars)   –  loaded B6 or Fc    RIII     /      DCs  for 
7 d and restimulated with anti-CD3 for 48 h. The amount of cytokines in 
culture supernatants was determined by ELISA (*, P   0.05; **, P   0.01; 
***, P   0.001). OTII TCR transgenic T cells were stimulated for 7 d with (B) 
B6 BMDCs or (C) Fc    RIII             DCs that were left untreated (Iso) or treated 
with anti-FcRIIb/RIII (2.4G2) and loaded with the agonist OVA  (323 – 339)  
peptide. T cells were subsequently restimulated for 48 h as in A, and the 
amount of cytokine production was determined by ELISA (*, P   0.05; 
**, P   0.01; ***, P   0.001). The data shown are representative of two 
independent experiments. The error bars indicate SEM between replicate 
stimulations in different wells.     JEM VOL. 204, August 6, 2007 
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Th2 cytokine production was found in CD4      T cells in the 
BAL fl  uid of mice sensitized with OVA-IC  –  loaded IL-10       /       
as determined by intracellular cytokine analysis (  Fig. 7 E  ). 
Collectively, these data argue for a central role of DC-de-
rived IL-10 in Fc      receptor  –  mediated augmentation of Th2 
diff  erentiation both in vitro and in vivo. 
  To determine if the failure to augment Th2 diff  erentia-
tion upon Fc      receptor ligation of IL-10       /       DCs would re-
sult in a corresponding failure to augment airway infl  ammation, 
we assessed the extent of airway infl  ammation in the recipi-
ent mice described above. Contrary to our expectation, Fc      
receptor ligation of IL-10       /       DCs augmented their ability to 
induce eosinophilia (  Fig. 7 F  ). Furthermore, there was a sub-
stantial and signifi  cant increase in T cells in the BAL fl  uid of 
mice sensitized with IL-10    −  /  −    DCs whether or not Fc      re-
ceptors were ligated. These data suggest that even though 
Fc      receptor  –  induced IL-10 contributes to the regulation of 
  We next evaluated if IL-10 production from the priming 
DCs infl  uenced in vivo Fc      receptor  –  mediated augmenta-
tion of Th2 diff  erentiation and airway infl  ammation. BM-
DCs generated from B6 or IL-10       /       mice loaded with either 
OVA-IC or OVA-IgG  Depl   were used to prime naive B6 re-
cipients as described in   Fig. 4  . The recipients were subse-
quently challenged by i.t. administration of soluble OVA, 
and the diff  erentiation status of T cells in the draining LNs 
was assessed by determining cytokine production by the cells 
upon restimulation with antigen. Similar to the results ob-
tained from in vitro experiments, Fc      receptor ligation of 
IL-10       /       DCs failed to augment production of Th2 cyto-
kines IL-4 and IL-5 from cells in the draining LNs (  Fig. 7 D  ). 
Priming with IL-10       /       DCs, as compared with priming with 
B6 DCs, led to an augmentation of IFN-      production from 
draining LNs cells, regardless of whether the DCs were 
loaded with OVA-IC or OVA-IgG  Depl  . A similar defect in 
  Figure 7.     IL-10 production from DCs plays a central role in the up-regulation of Th2 differentiation by immune complexes. (A) BMDCs 
generated from B6 or IL-10      /      mice were loaded with immune complexes (fi  lled bars) or control OVA-IgG  Depl   (open bars). After 24 h of culture, cytokine 
production from the BMDCs was measured by ELISA. Th2 differentiation status of OTII T cells stimulated with (B) IL-10      /      or (C) MCP-1      /      DCs  treated 
with immune complexes was assessed by analyzing cytokine production from the T cells as described in Fig. 6 A (**, P   0.01; ***, P   0.001). (D) Control 
OVA-IgG  Depl   (open bars) or OVA-IC (fi  lled bars)   –  loaded B6 or IL-10      /      DCs were instilled into naive B6 recipients that were subsequently challenged as 
described in Fig. 2. Cytokine production from cells in the draining LNs was determined by ELISA. (E) Quantitative analysis (top) and a representative fl  ow 
cytometry plot (bottom) of cytokine production from cells in the BAL as determined by intracellular staining. Data in the top panel are normalized to the 
amounts produced by recipients sensitized with OVA-IgG  Depl —loaded B6 DCs. (F) Analysis of cellular composition of the BAL fl  uid. These data are represen-
tative of three independent experiments. The error bars indicate SEM between (A  –  C) replicate stimulations in different wells or (D  –  F) variation between 
individual mice. At least eight mice per group were analyzed (*, P   0.05; **, P   0.01; ***, P   0.001; n.d., not detected).     1882 FC RIII REGULATES TH2 RESPONSES | Bandukwala et al.
soma mansoni   antigens. This model of sensitization and chal-
lenge with  S. mansoni   antigens is well established and previ ously 
reported by our lab as well as others (  41  –  44  ). B6 mice sensi-
tized with   S. mansoni   eggs and challenged with soluble egg 
antigen (SEA) develop a robust airway infl  ammation con-
sisting of 70  –  75% eosinophils, 10  –  15% T cells, and 10  –  15% 
macrophages. Furthermore, on the B6 background, this model 
of sensitization and challenge induces a log increase in air-
way eosinophilia compared with the OVA model of sensiti-
zation and challenge. We have previously established that 
eosinophilia in our model is totally dependent on both sensi-
tization and challenge (  42, 44  ). In the absence of either 
the sensitization or the challenge, the composition of the 
small number of BAL cells is predominantly macrophages and 
CD4      T cell diff  erentiation, IL-10 may not play a role in the 
augmentation of eosinophilia. 
  Development of airway infl  ammation and airway 
hyperresponsiveness is impaired in Fc    RIII-defi  cient mice 
  Our data demonstrate that ligation of Fc      receptors on DCs 
augments their ability to regulate Th2 responses in vitro and 
in vivo. We thus hypothesized that mice defi  cient in activat-
ing Fc      receptors would have impaired Th2-dependent in-
fl  ammatory responses. To investigate the role of activating 
Fc      receptors in the development of Th2-mediated airway 
disease, we assessed the severity of airway infl  ammation in 
FcR            /      , Fc     RI    −  /  −   , Fc     RIII       /      , and control B6 mice that 
were sensitized and challenged with noninfectious   Schisto-
  Figure 8.     Fc     RIII      /      mice exhibit a decrease in Th2-mediated airway infl  ammation and airway hyperresponsiveness. (A) FcR         /      ( n     9), 
Fc    RIII     /      ( n     8), Fc    RI     /       ( n     8), and B6 mice were sensitized with i.p. injection of inactivated   S. mansoni   eggs on day 0. These mice were challenged 
with i.t. administration of SEA on day 7. On day 11, the mice were killed and the cellular composition of the BAL fl  uid was examined by fl  ow cytometry 
(*, P   0.05; **, P   0.01). (B) Lung tissues from sensitized and challenged B6 and Fc    RIII     /      mice were fi  xed in 4% formalin and embedded in paraffi  n. The 
sections were stained with PAS or hematoxylin and eosin as noted. (C) Amount of IgE and SEA-specifi  c IgG  1   in the sera of sensitized and challenged mice 
was estimated by ELISA (**, P   0.01; P   0.0012 obtained by two-way ANOVA analysis). (D) Goblet cell metaplasia, perivascular, and peribronchial infl  am-
mation were scored as described in Materials and methods. Four mice per group were analyzed. (E) Rrs to methacholine was measured at day 4 after 
challenge (P   0.0053 by two-way ANOVA analysis). Data are representative of three independent experiments.     JEM VOL. 204, August 6, 2007 
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production from the lymph node cells of Fc     RI       /       mice 
upon in vitro restimulation (not depicted), demonstrating that 
there was a specifi   c defect in Th2 eff   ector functions in 
Fc     RIII       /       mice, but not in Fc     RI       /       mice. Thus, in addition 
indistinguishable from the BAL of mice without sensitiza-
tion and challenge. 
  In agreement with our hypothesis, mice lacking all acti-
vating Fc      receptors (FcR         /      ) exhibited a decrease in air-
way infl  ammation as represented by the decrease in eosinophils 
and CD4      cells in the BAL fl  uid as compared with control 
B6 mice (  Fig. 8 A  ).   Deletion of the Fc     RI receptor had no 
eff  ect on the Th2-mediated infl  ammatory response; however, 
there was a signifi  cant decrease in the numbers of eosinophils 
and CD4      T cells in the BAL fl  uid from Fc     RIII       /       mice as 
compared with the control B6 mice. Thus, despite sharing 
the common FcR      chain, the defect was specifi   c to the 
Fc     RIII receptor. 
  In addition to increased BAL eosinophilia, goblet cell 
metaplasia and mucus production are also indicative of the 
degree of infl  ammation. Histological examination of lungs 
showed that there was a decrease in mucus production as well 
as in the infl  ux of infl  ammatory cells in sensitized and chal-
lenged Fc     RIII       /       mice as compared with sensitized and 
challenged B6 mice (  Fig. 8, B and D  ). Furthermore, serum 
IgE levels and antigen-specifi  c IgG  1   levels were reduced in 
Fc     RIII       /       mice, suggesting a reduction in the capacity of 
these mice to mount Th2 responses to   S  .   mansoni   antigens 
(  Fig. 8 C  ). These data support our conclusion that expression 
of Fc     RIII is required for optimal induction of Th2-mediated 
airway infl  ammation. 
  Airway hyperresponsiveness is a hallmark of asthma and is 
often associated with increased airway infl  ammation (  45, 46  ). 
To investigate if the reduction in airway infl  ammation  in 
Fc     RIII       /       mice also leads to a reduction in airway hyperre-
sponsiveness, we measured respiratory system resistance (Rrs) 
changes in response to methacholine. Sensitized and chal-
lenged Fc     RIII       /       mice exhibited a reduction in Rrs to 
graded doses of methacholine as compared with similarly 
treated B6 mice (  Fig. 8 E  ). Collectively, these data demon-
strate that the sensitized and challenged Fc     RIII       /       mice de-
velop reduced Th2-dependent infl   ammatory responses and 
show a reduction in many of the major pathological features 
associated with human asthma. 
  Fc    RIII      /      mice exhibit reduced in vivo Th2 differentiation 
and cytokine production 
  To determine if the decrease in airway infl  ammation in 
Fc     RIII       /       mice was due to reduction in Th2 diff  erentia-
tion, we determined the cytokine production profi  le of ef-
fector cells in sensitized and challenged mice. Intracellular 
staining of CD4      T cells obtained from the lungs of 
Fc     RIII       /       mice demonstrated a defect in the ability to pro-
duce the hallmark Th2 cytokines IL-4 and IL-5, but exhib-
ited no defect in IFN-      production (representative contour 
plots are shown in   Fig. 9 A,   and the mean and SEM of fi  ve 
individual mice per experimental group are shown in   Fig. 9 B  ).   
Similarly, upon in vitro restimulation with antigen, there was 
a specifi  c reduction in IL-4, IL-5, and IL-13 secretion by T cells 
from the draining lymph nodes, whereas IFN-      production 
was unaff  ected (  Fig. 9 C  ). No defect was seen in Th2 cytokine 
  Figure 9.     In vivo Th2 differentiation and cytokine production are 
impaired in Fc     RIII      /      mice. B6 and Fc    RIII     /      mice were sensitized 
and challenged with S.   mansoni   as described in Fig. 8. (A) Cytokine pro-
duction of the effector cells in the lungs was determined by intracellular 
staining as described in Materials and methods. (B) Quantitative analysis 
of data presented in A (*, P   0.05). (C) LN cells were restimulated in vitro 
with SEA for 48 h, and the amount of cytokines in culture supernatants 
was determined by ELISA (**, P   0.01; ***, P   0.001). The data repre-
sented in this fi  gure were obtained from two independent experiments.     1884 FC RIII REGULATES TH2 RESPONSES | Bandukwala et al.
  Although our data suggest a role for activating Fc      recep-
tors on DCs in augmenting airway infl  ammation, it has been 
proposed that ligation of Fc      receptors on macrophages lim-
its the severity of airway infl  ammation (  60  ). Macrophages 
and DCs play diametrically opposite roles in the regulation of 
airway infl  ammation. Studies have demonstrated a suppres-
sive role for macrophages in airway infl  ammation, whereas 
myeloid DCs are found to be required for the induction and 
exacerbation of airway infl  ammation (  23, 25, 32, 61  ). Thus, 
it is possible that Fc      receptors may have distinct functions in 
macrophages and DCs. The diff  erence in Fc      receptor func-
tion on these two cell types is highlighted by the observations 
that Fc     RI, but not Fc     RIII, has an important role in aug-
menting IL-10 production from the macrophages (  62  ). In 
contrast to macrophages, our analysis of DCs from individual 
Fc      receptor  –  defi  cient mice has substantiated a role for 
Fc     RIII in augmenting LPS-induced IL-10 production in-
dependent of any other Fc      receptor. 
  In our study, we demonstrate a central role of DC-derived 
IL-10 production in the augmentation of Th2 diff  erentia-
tion induced upon Fc      receptor ligation both in vitro and 
in vivo. Nevertheless, the augmentation of eosinophilia in-
duced by Fc      receptor ligation on the priming DCs was 
found to be independent of IL-10 production from the DCs. 
Our data are supported by previous studies that demonstrate 
that IL-10       /       mice do not have a reduction in eosinophilia 
associated with mouse models of airway infl  ammation, even 
though IL-5 production is severely attenuated in IL-10       /       
mice (  63, 64  ). One possible explanation that could account 
for this disassociation of eosinophilia from Th2 diff  erentia-
tion may be that increased expansion of T cells observed in 
the absence of IL-10 may compensate for the reduction in 
Th2 cytokine production. Thus, even though IL-5 produc-
tion was reduced on a per-cell basis (  Fig. 7, D   and E), the in-
creased expansion of T cells observed in the BAL fl  uid of 
mice sensitized with IL-10       /       DCs (  Fig. 7 F  ) may result in 
equivalent levels of IL-5 in the airways and lead to the in-
crease in eosinophilia. A second possible explanation could 
be that Fc      receptor ligation on DCs may regulate Th2 dif-
ferentiation and augmentation of eosinophilic infl  ammation 
through distinct mechanisms. In either case, our data establish 
a clear requirement for Fc     RIII ligation on priming DCs for 
both the induction of optimal Th2 responses as well as the 
development of airway infl  ammation. 
  Although our data indicate a clear role for DC-derived 
IL-10 in the induction of Th2 diff  erentiation, other studies 
have reported that DC-derived IL-10 can induce the devel-
opment of regulatory T cells that can potently suppress Th2-
dependent infl   ammatory responses (  65, 66  ). One possible 
explanation for these apparently contradictory roles of IL-10 
could be the context in which IL-10 is produced by the DCs. 
The reports that have suggested a regulatory role for IL-10 
characterized the role of DC-derived IL-10 in a model of 
tolerance induction (  66  ). In this system, soluble OVA, in the 
absence of any TLR stimuli or other adjuvants, was instilled 
i.t. to induce tolerance. In contrast, all our experimental 
to the well-established role of IgE  –  Fc      receptor interaction 
in the exacerbation of allergic hyperresponsiveness, ligation 
of the activating Fc     RIII receptor can lead to augmented 
Th2 responses and the pathogenesis of airway disease. 
    DISCUSSION   
  This study establishes a role of Fc     RIII in the regulation of 
DC function that is distinct from its role in augmenting anti-
gen uptake and presentation. We fi  nd that signaling through 
Fc     RIII on BMDCs promotes Th2 diff  erentiation and leads 
to augmented Th2 eff  ector responses in vivo. These data ex-
tend upon previous fi  ndings by now demonstrating a specifi  c 
role of Fc     RIII on DCs for optimal Th2 responses, and by 
demonstrating that this signal is independent of the role of 
Fc     RIII in antigen presentation (  47  ). Previous studies have 
suggested that activating Fc      receptors could contribute to 
the severity of airway infl  ammation through the activation 
of Syk, a downstream kinase by which Fc      receptors are 
known to augment antigen presentation (  48  –  50  ). However, we 
demonstrate that signaling through Fc     RIII augments DC-
driven Th2 diff  erentiation, even when the DCs are loaded 
with an agonist peptide, eliminating the need for antigen 
uptake and processing. Further, we demonstrated that in the 
absence of Fc     RIII, immune complexes augment antigen 
presentation and induce augmented T cell proliferation with-
out enhancing Th2 diff  erentiation. These data uncouple the 
role of Fc     RIII in regulating Th2 diff  erentiation from its 
well-accepted role in augmenting antigen uptake and presen-
tation to T cells (  27, 28, 49, 51  –  53  ), and reveal a novel sig-
naling function of the activating Fc     RIII receptor. 
  We demonstrate that optimal Th2 responses and airway 
infl  ammation are dependent on Fc     RIII but not Fc     RI 
expression. Th2-dependent airway infl  ammation was induced 
by immunization with inactivated   S. mansoni   eggs, which in-
duce potent Th2 immunity accompanied by production of 
IgG  1   antibodies (  54  ). This IgG subclass preferentially stimu-
lates Fc     RIII as compared with Fc     RI (  55  ), and thus antigen-
specifi  c IgG1 may account for the selective requirement of 
Fc     RIII in augmenting Th2 responses. Whether Fc     RI sig-
naling has a contributing role in the augmentation of Th2-
mediated responses would need to be tested in experimental 
models where other IgG isotypes predominate. 
  An alternative and nonmutually exclusive explanation 
could be that Fc     RI and Fc     RIII have unique cellular expres-
sion profi  les. In mice, Fc     RIII is expressed on a variety of cell 
types that have been demonstrated to play a role in allergic dis-
ease, including DCs, macrophages, eosinophils (  56  ), and mast 
cells (  57  ). In contrast, Fc     RI is primarily expressed on mono-
cytes, macrophages, and DCs (  58  ). Signaling via Fc     RIII on 
mast cells has been demonstrated to induce mast cell degranu-
lation and release of soluble mediators that have a role in the 
regulation of Th2 diff  erentiation (  59  ). Although Fc     RI cannot 
compensate for the requirement of Fc     RIII, a contribution of 
Fc     RI cannot be ruled out. Thus, multiple mechanisms might 
contribute to the Th2 defect observed in Fc     RIII       /       mice 
sensitized and challenged with   S. mansoni   antigens. JEM VOL. 204, August 6, 2007 
ARTICLE
1885
  We propose that Fc     RIII may play a   “  co-stimulatory  ”   
role and diff  erentially modulate TLR-induced DC cytokine 
production. This co-stimulatory function of Fc      receptors 
suggests an important link between the innate and adaptive 
immune responses. Antibody production by B cells could po-
tentially infl  uence the activation and function of innate im-
mune cells such as DCs via ligation of Fc      receptors. This 
idea is further supported by the fi  ndings that B cell  –  defi  cient 
mice produce reduced Th2 responses (  73, 74  ). As IgG pro-
duction occurs relatively late after initial sensitization with 
antigen, the infl  uence of Fc      receptor signaling on DCs dur-
ing initial priming is less likely. However, Fc      receptor sig-
naling could infl  uence the magnitude of ongoing and recall 
Th2 responses by further augmenting Th2 diff  erentiation 
during secondary responses. Thus, IgG antibodies induced un-
der Th2 conditions may form a feedback loop by ligating 
Fc     RIII on DCs, thereby enhancing an established infl  am-
matory Th2 response. 
  Allergies and asthma are chronic disorders whose severity 
depends upon continued Th2 responses to the allergen. Our 
data suggest a central role for activating Fc      receptors in regu-
lating Th2 responses and may provide a molecular basis for the 
proinfl  ammatory role of IgG in diseases such as allergies and 
asthma. However, depending on its subclass, in addition to 
activating Fc      receptors allergen-specifi  c IgG also has the 
potential to engage the inhibitory Fc      receptor Fc     RIIb. Inter-
estingly, ligation of the inhibitory receptors has been reported 
to suppress infl  ammatory responses. Zhu et al. (13) have de-
scribed a chimeric Fel d1  –  human Fc      fusion protein that sup-
presses IgE-mediated mast cell activation by coligation of 
Fc     RIIb. Further, Fc     RIIb ligation has been shown to aug-
ment mucosal tolerance and limit infl  ammation to innocuous 
antigens (  14  ). Thus, the relative contributions of diff  erent Fc 
receptor family members in the development and progression 
of infl  ammatory diseases may be exceedingly complex. 
  Allergen-specifi  c IgG may have diff  erent functions in dis-
tinct infl  ammatory processes. This complexity is highlighted 
by a recent report that suggests that in immediate anaphylac-
tic eff  ector responses, which are largely governed by innate cells 
such as macrophages and mast cells, allergen-specifi  c IgG may 
have a suppressive role (  75  ). In contrast, our study addresses 
the role of allergen-specifi  c IgG in the priming of adaptive 
immune responses that are likely to be of explicit importance 
in more chronic Th2-mediated diseases. 
  Additionally, the amount of allergen-specifi  c IgG present 
in the serum of sensitized individuals may also diff  erentially 
infl  uence infl  ammatory processes. In the same report (  75  ), 
it was demonstrated that the suppressive eff  ects of the in-
hibitory Fc     RIIb were most evident only when the allergen 
amount was low and the amount of allergen-specifi  c IgG was 
high. It is quite likely that the conditions, in which allergen-
specifi  c IgG may have an inhibitory role, may not always 
exist under physiological exposure and response to allergens 
in a diverse group of individuals. It is in fact tempting to specu-
late that diff  erent genetic predispositions and environmental 
infl  uences may in turn impact on the relative amounts of 
protocols use the TLR-4 agonist LPS, which is a strong stim-
ulator of proinfl  ammatory cytokines and a potent activator 
of DC functions, in conjunction with Fc      receptor ligation. 
These DCs are exposed to a   “  danger  ”   signal and are primed 
to activate the adaptive immune response. Thus, in the pres-
ence of additional proinfl   ammatory mediators, IL-10 may 
serve to modulate the T helper response toward a Th2 bias 
rather than a tolerogenic response. This hypothesis is also 
supported by studies that report that ligation of certain pro-
infl  ammatory stimuli, such as the TLR-2 agonist zymosan and 
Pam-3-Cys, lead to augmented IL-10 production by the DCs, 
which in turn leads to increased Th2 responses in vitro and 
in vivo (  67, 68  ). 
  Although our data clearly demonstrate a positive contri-
bution of DC IL-10 production in the augmentation of Th2 
diff  erentiation upon Fc     RIII engagement, the mechanism by 
which IL-10 production from the DCs leads to the increased 
Th2 diff  erentiation remains unclear. One mechanism could 
be that Fc     RIII-mediated increase in DC IL-10 production 
could directly modulate T cell function. As both T cells and 
DCs express IL-10 receptors, another likely mechanism could 
be that IL-10 modulates DC function in an autocrine man-
ner, which in turn aff  ects T cell diff  erentiation. In fact, sup-
pression of IL-12 production due to the autocrine eff  ects of 
IL-10 has been suggested to play a role in increased Th2 dif-
ferentiation induced upon treatment of DCs with PGE  2   and 
steroids (  69, 70  ). However, our results with IL-10       /       DCs 
argue for an alternate role of IL-10 in the augmentation of 
Th2 diff  erentiation induced upon Fc     RIII ligation on DCs. 
We report that the downmodulation of IL-12 production 
upon Fc     RIII engagement does not require IL-10 produc-
tion from the DCs. IL-10       /       DCs potently suppressed IL-12 
production upon Fc      receptor engagement (  Fig. 7 A  ). How-
ever, IL-10       /       DCs failed to induce Th2 diff  erentiation upon 
Fc      receptor ligation. These data clearly dissociate the ability 
of Fc      receptors to suppress DC IL-12 production from their 
ability to promote Th2 diff  erentiation and lead us to con-
clude an alternate and important role of IL-10 production in 
this process. In support, previous reports have also demon-
strated that IL-12 absence or suppression is not suffi   cient for 
the induction of Th2 responses by DCs (  37  ,   71  ). 
  The role of IL-10 production from the T cells remains 
unclear. Our data is in concordance with the model proposed 
by Umetsu et al. (72) that suggests that Th2 cells and IL-10  –
  expressing regulatory T cells may have a common precursor 
and diverge further along their developmental pathway. 
Whereas Th2 cells express Th2 cytokines such as IL-4, IL-5, 
and IL-13 in addition to IL-10, regulatory cells either de-
velop to exclusively produce IL-10 or may down modulate 
the production of the proinfl  ammatory Th2 cytokines IL-4, 
IL-5, and IL-13 while retaining IL-10 production. The cyto-
kine profi  le of T cells primed with OVA-IC  –  loaded DCs 
exhibits an increase in all of the bonafi  de Th2 cytokines in 
addition to IL-10. Thus, our data support the notion that 
upon Fc      receptor ligation, DCs bias the generation of Th2 
responses and not the generation of regulatory T cells. 1886 FC RIII REGULATES TH2 RESPONSES | Bandukwala et al.
Lysate assay (Cambrex). The monoclonal antibody 2.4G2 and the con-
trol rat IgG antibody were purifi  ed from culture supernatants as described 
previously (  77  ). 
  Production of BMDCs.     DCs were generated by a technique described by 
Lutz et al. (  78  ). In brief, bone marrow was fl  ushed from the femurs of mice, 
and cells were cultured in bacteriological Petri dishes at 2   10  5   cells/ml. 
The cultures were supplemented with 20 ng/ml GM-CSF (PeproTech) and 
replenished on days 3 and 6. On day 8, the suspension cells were harvested 
and found to contain  85% CD11c      cells. 
  Stimulation of BMDCs.     For stimulation, 5   10  5   BMDCs were cultured 
in 24-well plates with OVA-IC or OVA-IgG  Depl   at a fi  nal OVA concentra-
tion of 100      g/ml. For stimulation with 2.4G2, 24-well plates were coated 
with 500  l of the indicated concentrations of 2.4G2 or control rat IgG in 
PBS for 2 h at 37  °  C. BMDCs were transferred to the coated plates and 
cultured in the presence of 10 ng/ml LPS. Cytokine levels in the superna-
tant were estimated at 24 h. The level of cytokine produced in DC cultures 
that were neither stimulated with LPS or OVA-IC is below the level of 
detection, which is 32 pg/ml for IL-10, 64 pg/ml for IL-12p70, and 80 pg/ml 
for MCP-1. 
  Induction and assessment of airway infl  ammation.     Mice were sensi-
tized and challenged with   S  .   mansoni   antigens as described previously (  41  ). 
In brief, mice were immunized i.p. on day 0 with 5,000 inactivated   S  .   mansoni   
eggs. Mice were challenged on day 7 via i.t. delivery of 5  g SEA and killed 
4 d later. 
  Mice were sensitized to OVA using adoptive transfer of antigen-loaded 
BMDCs as described previously, with minor modifi  cations (  32  ). 10  6   BMDCs 
from B6 or Fc     RIII       /       mice were loaded with OVA-IgG  Depl   or OVA-IC 
(fi  nal OVA concentration of 100      g/ml) for 24 h, harvested, and instilled i.t. 
into naive B6 recipients on day 0. On days 7, 8, and 9, the mice were chal-
lenged by i.t. aspiration of 100      g OVA and killed on day 10. 
  BAL was performed by delivering 0.8 ml cold PBS into the airway via 
a trachea cannula and gently aspirating the fl  uid. The lavage was repeated 
three times to recover a total volume of 2  –  3 ml. The cells were stained 
with trypan blue to determine viability, and total nucleated cell counts 
were obtained using a hemocytometer. The percentage of CCR3      eosino-
phils, CD4      T cells, and CD8      T cells in the BAL was determined using 
fl  ow cytometry. 
  Histology.     Lungs were removed from mice after BAL and fi  xed by immer-
sion into 4% formalin. Lobes were sectioned sagitally, embedded in paraffi   n, 
cut into 5- m sections, and stained with hematoxylin and eosin for analysis 
of cellular infi  ltrates or with periodic acid schiff   (PAS) for analysis of mucus-
containing cells. The score of peribronchiolar and perivascular infl  ammation 
was determined as described previously (  44  ). In brief, for the quantifi  cation, 
the airways were scored on a scale of 0 to 4, with 0 being negative and 1  –  4 
being positive for PAS-staining bronchi. The extent of mucus production in 
positive bronchi was scored as follows: 1, 5  –  25%; 2, 25  –  50%; 3, 50  –  75%; 
and 4,  75%. Peribronchiolar and perivascular infl  ammation was scored as 
follows: 0, normal; 1, few cells; 2, a ring of infl  ammatory cells one  –  cell layer 
deep; 3, a ring of infl  ammatory cells two- to four-cells deep; and 4, a ring of 
infl  ammatory cells of more than four-cells deep. 
  Airway responsiveness.     Rrs was measured through a computer-controlled 
small animal ventilator (Flexivent; SCIREQ) as described previously (  79  ). 
Each mouse was challenged with increasing doses of methacholine (0, 10, 20, 
40, and 80  g in saline) administered i.v. After each challenge, Rrs was re-
corded during tidal breathing every 10 s for 2 min. Maximum values of Rrs 
were taken and expressed in terms of percentage change from baseline after 
saline aerosol. 
  Isolation of lung cells.     Lungs were disassociated by agitating the tissue for 
1 h in 20 ml of digestion buff  er (85 U/ml hyaluronidase [Sigma-Aldrich], 
allergen present in an individual as well as their ability to 
produce allergen-specifi  c IgG antibodies. In any event, these 
studies are in agreement with our fi  ndings that Fc     RIIb can 
limit Fc     RIII-mediated augmentation of IL-10 production 
from BMDCs, and together emphasize the importance of 
selectively targeting diff  erent Fc      receptors for treatment of 
allergic diseases. 
  Translation of our studies to human DC and Th2 diseases 
remains to be explored. Interestingly, a report by Banki et al. 
suggests that, similar to our results, ligation of activating Fc      
receptors modulates the function of human DCs (  76  ). They 
demonstrated that cross-linking of CD32a, an activating Fc      
receptor, on human DCs induces their functional maturation 
along with an increase in IL-10 production. Due to diff  er-
ences in Fc      receptor expression and function between hu-
mans and mice, it is likely that the exact molecular identity of 
the specifi  c Fc      receptor may be diff  erent. Nevertheless, it is 
conceivable that in addition to IgE, allergen-specifi  c IgG may 
also modulate the severity of allergic responses in humans. In 
light of these reports and our fi  ndings, therapeutic strategies 
such as   “  allergen hyposensitization  ”   that aim to switch anti-
body production from IgE to IgG need to take into account 
the IgG subclasses induced and their relative affi   nities for dif-
ferent Fc      receptors. Inadvertent induction of IgG subclasses 
that activate Fc     RIII may exacerbate rather than ameliorate 
allergic diseases. Furthermore, therapeutic antibodies clinically 
used to neutralize proinfl  ammatory molecules are largely of the 
IgG isotypes. Infusion of large doses of these antibodies may lead 
to the generation of immune complexes, leading to Fc     RIII 
activation that in turn could bias the CD4      T cell response 
toward a Th2 phenotype. Thus, our studies now demonstrate 
a novel role for Fc     RIII in Th2 diff  erentiation that must be 
considered in the future design of immunotherapies to re-
duce adverse eff  ects on therapeutic effi   cacy. 
  MATERIALS AND METHODS 
  Mice.     Fc     RI /   (18) and Fc     RIII /  (17) mice have been backcrossed 
6 and 13 generations, respectively, on the B6 background. Female 8  –  12-wk-
old BALB/c and B6 mice were purchased from The Division of Cancer 
Treatment at the National Cancer Institute or from Charles River Labora-
tories. Fc     RIIb / , FcR  / , and Fc     RIIb / FcR      /  mice were purchased 
from Taconic. C.C3-  Tlr4  Lps-d     mice congenic for the   Tlr4  Lps-d     interval from 
C3H/HeJ strain and IL-10 /  mice were purchased from The Jackson 
Laboratory. MCP-1 /  mice were provided by W.J. Karpus (Northwestern 
University, Chicago, IL). The OTII TCR (specifi  c for OVA  323  –  339   peptide) 
transgenic mice were bred and maintained at the University of Chicago. 
Animals were housed in a specifi  c pathogen-free facility maintained by the 
University of Chicago Animal Resources Center. The studies detailed herein 
conform to the principles set forth by the Animal Welfare Act and the 
National Institutes of Health guidelines for the care and use of animals in 
biomedical research. 
  Reagents.     Grade V chicken egg OVA and rabbit anti  –  chicken egg OVA 
IgG were purchased from Sigma-Aldrich. IgG  –  OVA-ICs were made by 
mixing a 4:1 excess of anti-OVA:OVA at 37  °  C for 30 min. To control for 
nonspecifi  c eff  ects from the antisera, an aliquot of the sera was passed over 
a protein G column to deplete all IgG present in the serum. This aliquot 
was mixed with OVA (OVA-IgG  Depl  ) and used as the control for OVA-IC. 
Endotoxin levels present in OVA, OVA-IgG  Depl  , and OVA-IC were 22.1, 17.8, 
and 38 EU/mg, respectively, as determined by the Limulus Amebocyte JEM VOL. 204, August 6, 2007 
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50 U/ml DNaseI [Boehinger Mannheim], and 1.0 mg/ml collagenase P [Boeh-
ringer Manheim]). The digest was passed through nytex fi  lter, and RBCs 
were depleted with ammonium chloride-potassium lysing buff  er. Dead cells 
were removed by centrifugation through Ficoll-Hypaque (Sigma-Aldrich). 
  Cytokine analysis.     Cells from the draining LNs were cultured with 5  g/ml 
SEA or 100  g/ml OVA at 4   10  5   cells/well for 48 h, and supernatants 
were collected and analyzed by ELISA or cytometric bead array according to 
the manufacturer  ’  s protocol (R  &  D Systems and BD Biosciences). For intra-
cellular cytokine analysis, cells were stimulated overnight with 50 ng/ml 
PMA and 500 ng/ml ionomycin in the presence of 1      g/ml brefeldin A and 
2 mM monensin. 
  ELISPOT.     ELISA spot plates (Cellular Technology Limited) were coated 
with 2  g/ml rat anti  –  mouse IL-4, IL-5, and IFN-      antibodies (BD Bio-
sciences). Plates were blocked with PBS/0.1% BSA and washed with PBS. 
Lung cells were cultured on the plates for 16 h at 37  °  C in the presence or 
absence of 100  g/ml OVA. The ELISPOT plates were scanned by an 
ImmunoSpot Series 2 Analyzer (Cellular Technology Limited). 
  Flow cytometric analysis.     Lung cells were suspended in 100  l of FACS 
buff  er (PBS containing 0.1% sodium azide and 1% BSA) and labeled with 
APC-, FITC-, or PE-conjugated anti-CD4, CD8 (BD Biosciences), IL-4, 
IFN-     , and TNF-      (eBioscience), and CCR3 and IL-5 (R  &  D Systems) an-
tibodies. For detection of intracellular cytokines, cells were fi  xed with 2% 
paraformaldehyde and permeabilized with 0.5% saponin in PBS containing 
0.1% BSA. After fi  xation and permeabalization, cells were incubated with 
fl  uorochrome-conjugated anti-cytokine antibodies. Flow cytometric analy-
sis was performed with a FACSCalibur or LSRII (BD Biosciences), and the 
data were analyzed with FlowJo software (Tree Star Inc.). 
  Measurement of OVA uptake and processing.     To quantify antigen 
processing, cells were pulsed with DQ-OVA (Invitrogen) or DQ-OVA-IC 
(generated by incubating 4:1 excess of anti-OVA:DQ-OVA at 37  °  C for 
30 min) for 15 min at 37  °  C to allow internalization. The cells were washed ex-
tensively with cold FACS buff  er and incubated at 37  °  C for the indicated 
time points. Nonspecifi  c binding of DQ-OVA was assessed by incubating 
with DQ-OVA on ice for 60 min. After extensive washing with ice-cold 
FACS buff  er, cells were stained with anti-CD11c and analyzed by fl  ow 
cytometry. Amount of OVA internalized and processed by the CD11c      DCs 
was quantifi  ed as the FITC mean fl  uorescence intensity. 
  T cell enrichment.     Total LN cells from OTII mice were passed through a 
nylon wool column, and nonadherent cells were collected. T cells were further 
purifi  ed by complement-mediated cytotoxic treatment with anti  –  heat-stable 
antigen (J11D) antibodies (American Type Culture Collection). Dead cells 
were removed by centrifugation through Ficoll-Hypaque (Sigma-Aldrich). 
T cell purity was analyzed by fl  ow cytometry was consistently  97% CD3     . 
  T cell proliferation and diff  erentiation.     To determine proliferation, 
2.5   10  4   T cells from TCR transgenic OTII mice were labeled with CFSE and 
co-cultured with 2.5   10  3   OVA- or OVA-IC  –  stimulated BMDCs for 
96 h. To determine the diff  erentiation of the T cells, the purifi  ed T cells were 
co-cultured with the DCs as described above, and after 7 d of culture the 
cells were harvested and dead cells were removed by centrifugation through 
a Ficoll gradient. The cells were equalized and restimulated for an additional 
48 h on anti-CD3  –  coated plates. 
  Statistical analysis.     All statistics were done using an unpaired Student  ’  s 
two-tailed   t   test (*, P   0.05; **, P   0.01; ***, P   0.001) or two-way 
ANOVA. Error bars represent SEM. 
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